Abstract 82 Table 1
EndpointsAL (n=5)TTR wt senile (n=10)TTR mutant (n=12)Non-Amyloid Restrictive Control (n=18)Log-Rank P-Value
3 Year Survival 100.0% 90.0% 83.3% 94.4% 0.790
3 Year Freedom from CAV 80.0% 80.0% 83.3% 88.9% 0.990
3-Freedom from NF-MACE 100.0% 90.0% 75.0% 100.0% 0.112
3-Freedom from Any-Treated Rejection 100.0% 100.0% 91.7% 94.4% 0.619
3 Year Freedom from Acute Cellular Rejection 100.0% 100.0% 91.7% 100.0% 0.518
3 Year Freedom from Antibody-Mediated Rejection 100.0% 100.0% 100.0% 94.4% 0.367